Ori Biotech addressing issues in patients accessing advanced cell and gene therapies

Ori Biotech discusses why paper is the enemy of scale in CGT manufacturing

www.bioprocessintl.com

Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech

https://www.fiercepharma.com

Regulatory challenges and success in Series B: an interview with Jason C. Foster

www.regmednet.com